3b4f: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:3b4f.jpg|left|200px]] | [[Image:3b4f.jpg|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_3b4f", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
| | --> | ||
| | {{STRUCTURE_3b4f| PDB=3b4f | SCENE= }} | ||
}} | |||
'''Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with twelve mammalian isoforms: kinetic and X-Ray crystallographic studies''' | '''Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with twelve mammalian isoforms: kinetic and X-Ray crystallographic studies''' | ||
Line 32: | Line 29: | ||
[[Category: Supuran, c t.]] | [[Category: Supuran, c t.]] | ||
[[Category: Temperini, c.]] | [[Category: Temperini, c.]] | ||
[[Category: | [[Category: Acetylation]] | ||
[[Category: | [[Category: Carbonic anhydrase]] | ||
[[Category: | [[Category: Crystal structure]] | ||
[[Category: | [[Category: Cytoplasm]] | ||
[[Category: | [[Category: Disease mutation]] | ||
[[Category: | [[Category: Inhibitor]] | ||
[[Category: | [[Category: Lyase]] | ||
[[Category: | [[Category: Metal-binding]] | ||
[[Category: Polymorphism]] | |||
[[Category: | [[Category: Sulfonamide]] | ||
[[Category: | [[Category: Zinc]] | ||
[[Category: | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 20:23:04 2008'' | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on |
Revision as of 20:23, 4 May 2008
Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with twelve mammalian isoforms: kinetic and X-Ray crystallographic studies
OverviewOverview
2-(Hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide was tested for its interaction with 12 carbonic anhydrase (CA, EC 4.2.1.1) isoforms in the search of compounds with good inhibitory activity against isozymes with medicinal chemistry applications, such as CA I, II, VA, VB, VII, IX, and XII among others. This sulfonamide is a potent inhibitor of CA I and II (K(I)s of 7.2-7.5 nM), a medium potency inhibitor of CA VII, IX, XII, and XIV, and a weak inhibitor against the other ubiquitous isoforms, making it thus a very interesting clinical candidate for situations in which a strong inhibition of CA I and II is needed. The crystal structure of the hCA II adduct of this sulfonamide revealed many favorable interactions between the inhibitor and the enzyme which explain its strong low nanomolar affinity for this isoform but may also be exploited for the design of effective inhibitors incorporating bicyclic moieties.
About this StructureAbout this Structure
3B4F is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies., Guzel O, Temperini C, Innocenti A, Scozzafava A, Salman A, Supuran CT, Bioorg Med Chem Lett. 2008 Jan 1;18(1):152-8. Epub 2007 Nov 4. PMID:18024029 Page seeded by OCA on Sun May 4 20:23:04 2008